FI964285A0 - Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet - Google Patents

Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet

Info

Publication number
FI964285A0
FI964285A0 FI964285A FI964285A FI964285A0 FI 964285 A0 FI964285 A0 FI 964285A0 FI 964285 A FI964285 A FI 964285A FI 964285 A FI964285 A FI 964285A FI 964285 A0 FI964285 A0 FI 964285A0
Authority
FI
Finland
Prior art keywords
pharmaceutical preparations
preparations based
taxane class
derivatives belonging
docetaxel
Prior art date
Application number
FI964285A
Other languages
English (en)
Swedish (sv)
Other versions
FI118204B (fi
FI964285A (fi
Inventor
Manfred Durr
Joerg-Christian Hager
Armin Wendel
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI964285A0 publication Critical patent/FI964285A0/fi
Publication of FI964285A publication Critical patent/FI964285A/fi
Application granted granted Critical
Publication of FI118204B publication Critical patent/FI118204B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
FI964285A 1994-04-25 1996-10-24 Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet FI118204B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9404951 1994-04-25
FR9404951A FR2718963B1 (fr) 1994-04-25 1994-04-25 Nouvelle composition pharmaceutique à base de taxoïdes.
FR9500532 1995-04-24
PCT/FR1995/000532 WO1995028923A1 (fr) 1994-04-25 1995-04-24 Compositions pharmaceutiques a base de derives de la classe des taxanes

Publications (3)

Publication Number Publication Date
FI964285A0 true FI964285A0 (fi) 1996-10-24
FI964285A FI964285A (fi) 1996-10-24
FI118204B FI118204B (fi) 2007-08-31

Family

ID=9462475

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964285A FI118204B (fi) 1994-04-25 1996-10-24 Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet

Country Status (26)

Country Link
US (1) US5670536A (fi)
EP (1) EP0758231B1 (fi)
JP (1) JP3950993B2 (fi)
KR (1) KR100401119B1 (fi)
CN (1) CN1283243C (fi)
AT (1) ATE202931T1 (fi)
AU (1) AU691283B2 (fi)
BR (1) BR9507846A (fi)
CZ (1) CZ285720B6 (fi)
DE (1) DE69521693T2 (fi)
DK (1) DK0758231T3 (fi)
ES (1) ES2160163T3 (fi)
FI (1) FI118204B (fi)
FR (1) FR2718963B1 (fi)
GE (1) GEP20002069B (fi)
GR (1) GR3036211T3 (fi)
HU (1) HU225971B1 (fi)
NO (1) NO314745B1 (fi)
NZ (1) NZ285122A (fi)
PL (1) PL179623B1 (fi)
PT (1) PT758231E (fi)
RU (1) RU2157200C2 (fi)
SK (1) SK283255B6 (fi)
TW (1) TW416849B (fi)
WO (1) WO1995028923A1 (fi)
ZA (1) ZA953358B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6395770B1 (en) 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
EP1023050B1 (en) * 1997-06-27 2013-09-25 Abraxis BioScience, LLC Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
JP4644364B2 (ja) * 1998-02-05 2011-03-02 ノバルティス アーゲー エポシロン組成物
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
DE10255285A1 (de) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Selbst formende Phospholipid-Gele
US20050152979A1 (en) * 2003-09-05 2005-07-14 Cell Therapeutics, Inc. Hydrophobic drug compositions containing reconstitution enhancer
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US7446126B2 (en) * 2004-10-08 2008-11-04 Indena S.P.A. Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
EP1987813A1 (en) * 2007-05-04 2008-11-05 Pharmatex Italia Srl Injectable pharmaceutical formulation of taxoids in stable liposomes
EP2205215A2 (en) * 2007-10-01 2010-07-14 Intas Pharmaceuticals Limited Docetaxel injectable composition, being absolutely free of ethanol
WO2009061458A1 (en) * 2007-11-07 2009-05-14 Amfit, Inc. Impression foam digital scanner
ES2344674B1 (es) * 2008-08-07 2011-06-29 Gp Pharm, S.A. Composicion farmaceutica inyectable de taxanos.
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
WO2012156999A1 (en) * 2011-05-19 2012-11-22 Manu Chaudhary Ready to use docetaxel formulation
EP2875814B1 (en) 2012-07-19 2018-08-22 FUJIFILM Corporation Liquid composition containing taxane-based active ingredient, process for producing same, and liquid medicinal preparation
EA022182B1 (ru) * 2012-12-24 2015-11-30 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы доцетаксела

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534899A (en) * 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
US4507217A (en) * 1983-03-07 1985-03-26 Lipid Specialties, Inc. Magnetic compositions and magnetic memory devices prepared therefrom
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
WO1993018751A1 (en) * 1992-03-23 1993-09-30 Georgetown University Liposome encapsulated taxol and a method of using the same
AU6833994A (en) * 1993-05-17 1994-12-12 Liposome Company, Inc., The Incorporation of taxol into liposomes and gels
WO1994026253A1 (en) * 1993-05-19 1994-11-24 The Liposome Company, Inc. Liposome having a multicomponent bilayer which contains a bioactive agent as an integral component of the bilayer
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation

Also Published As

Publication number Publication date
DE69521693T2 (de) 2002-05-02
PT758231E (pt) 2001-11-30
GEP20002069B (en) 2000-05-10
JPH09512261A (ja) 1997-12-09
HUT75513A (en) 1997-05-28
SK283255B6 (sk) 2003-04-01
KR100401119B1 (ko) 2004-03-19
KR970702033A (ko) 1997-05-13
FI118204B (fi) 2007-08-31
NZ285122A (en) 1998-06-26
BR9507846A (pt) 1997-09-16
AU691283B2 (en) 1998-05-14
NO964433D0 (no) 1996-10-18
US5670536A (en) 1997-09-23
SK135696A3 (en) 1997-05-07
CN1283243C (zh) 2006-11-08
AU2412695A (en) 1995-11-16
PL179623B1 (pl) 2000-10-31
ZA953358B (en) 1996-01-17
ES2160163T3 (es) 2001-11-01
FI964285A (fi) 1996-10-24
DE69521693D1 (de) 2001-08-16
RU2157200C2 (ru) 2000-10-10
CZ285720B6 (cs) 1999-10-13
HU9602942D0 (en) 1996-12-30
NO964433L (no) 1996-10-18
FR2718963B1 (fr) 1996-05-24
TW416849B (en) 2001-01-01
CN1146722A (zh) 1997-04-02
EP0758231B1 (fr) 2001-07-11
PL316942A1 (en) 1997-02-17
EP0758231A1 (fr) 1997-02-19
WO1995028923A1 (fr) 1995-11-02
ATE202931T1 (de) 2001-07-15
JP3950993B2 (ja) 2007-08-01
GR3036211T3 (en) 2001-10-31
NO314745B1 (no) 2003-05-19
DK0758231T3 (da) 2001-09-24
HU225971B1 (en) 2008-01-28
FR2718963A1 (fr) 1995-10-27
CZ309396A3 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
FI964285A0 (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
PT977562E (pt) Metodos e composicoes para administracao de taxanos
EP0693924A4 (en) METHODS OF ADMINISTRATION -i (IN VIVO) OF BIOLOGICAL SUBSTANCES AND COMPOSITIONS USED IN SUCH METHODS
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
HUP0301405A2 (hu) Fokozott oldékonyságú gyógyhatású komponenseket tartalmazó készítmények
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
DE69809074D1 (de) Herstellung von arzneimitteln
SE0003449D0 (sv) Anticancer compositions
BR9810495A (pt) Composição farmacêutica
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
NO954545L (no) Inklusjonskomplekser av taxol eller taxoter, eller taxus-ekstrakt dannet med syklodekstrin, samt fremstilling og anvendelse derav
DK0917460T3 (da) Cyclosporin-formulering
ATE223700T1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
DE3778826D1 (de) Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung.
MX9604984A (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.
BR0215498A (pt) Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes
KR950702942A (ko) 암의 간전이 억제용 의약 조성물 및 간암 치료용 의약 조성물(pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer)

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118204

Country of ref document: FI

MM Patent lapsed